Ms. Sriram has over two decades of experience in biopharmaceutical R&D, with hands-on knowledge of driving biologics from early research to human clinical trials. She joined GangaGen in 2001 and has held various leadership roles, helping to establish the R&D infrastructure in the Company. In these roles, she has led multidisciplinary teams towards the development of therapeutic phages and phage-derived antibacterial proteins for human therapy.
Prior to joining GangaGen, Ms. Sriram gained extensive experience in R&D and preclinical development of Bio-therapeutics at Dr. Reddy’s Laboratories. Earlier in her career, she developed DNA-based diagnostics for cerebral malaria and researched anti-malarial compounds for in vitro and in vivo efficacy at Astra Research Center India (Astra Zeneca). After completing her Master’s Degree in Clinical Biochemistry, she pursued a Master of Philosophy in Biotechnology from the University of Poona.
Ms. Sriram has authored several scientific publications in peer-reviewed journals and is an inventor on several patents related to GangaGen’s phage and phage-derived technology.